In a statement responding to stomach paralysis concerns prior to the lawsuit, Novo Nordisk, the maker of Ozempic and Wegovy, said, Gastrointestinal (GI) events are well-known side effects of the GLP-1 class
Common Side Effects About 50% to 60% of people get stomach problems when they start GLP-1 medicines
These medications, which mimic the natural GLP-1 hormone, can help regulate appetite, increase feelings of fullness, and reduce calorie intake
They work by: Common examples include semaglutide and tirzepatide-based medications
In severe cases, reconstructive surgery may be required
View the current NuraPatch offer (official NuraPatch page) As consumer interest in botanical weight-management support continues into 2026, search behavior shows growing curiosity around non-pill supplement formats, including transdermal patches